| Khubchandani S, Deeb G, Smiley SL, et al.
Fatal Hyperacute Graft-versus-Host Disease following Denileukin Diftitox Treatment for Recurrent T Cell Lymphoma after Allogeneic Stem Cell Transplantation. [Letter]
Biol Blood Marrow Transplant 2009 Jul; 15(7):887-90.
Full Citation | Find Related Articles |
| Alousi AM, Weisdorf DJ, Logan BR, et al.
Etanercept, mycophenolate, denileukin or pentostatin plus corticosteroids for acute graft vs. host disease: a randomized phase II trial from the BMT CTN. [JOURNAL ARTICLE]
Blood 2009 May 14.
Abstract | Full Citation | Find Related Articles |
| Gerena-Lewis M, Crawford J, Bonomi P, et al.
A Phase II Trial of Denileukin Diftitox in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer. [JOURNAL ARTICLE]
Am J Clin Oncol 2009 May 8.
Abstract | Full Citation | Find Related Articles |
| Holzman DC
Whatever happened to immunotoxins? Research, and hope, are still alive. [News]
J Natl Cancer Inst 2009 May 6; 101(9):624-5.
Full Citation | Publisher Full Text | Find Related Articles |
| Cheson BD
Novel therapies for peripheral T-cell non-Hodgkin's lymphomas. [JOURNAL ARTICLE]
Curr Opin Hematol 2009 Apr 13.
Abstract | Full Citation | Find Related Articles |
| Kreitman RJ
Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies. [Journal Article]
BioDrugs 2009; 23(1):1-13.
Abstract | Full Citation | Find Related Articles |
| Ruter J, Barnett BG, Kryczek I, et al.
Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines. [Journal Article]
Front Biosci 2009.:1761-70.
Abstract | Full Citation | Find Related Articles |
| Klemke CD, Goerdt S
Molecular biology and targeted therapy of cutaneous T-cell lymphomas. [Journal Article]
G Ital Dermatol Venereol 2008 Dec; 143(6):365-74.
Abstract | Full Citation | Find Related Articles |
| Zalom M, Lill M, Lukic D, et al.
Autologous graft-versus-host disease after denileukin diftitox and autologous stem cell transplantation for refractory T-cell lymphoma. [LETTER]
Leuk Lymphoma 2008 Dec 29.:1-3.
Full Citation |
| Horwitz SM
Novel Therapies for Cutaneous T-Cell Lymphomas. [JOURNAL ARTICLE]
Clin Lymphoma Myeloma 2008 Dec 1.:S187-S192.
Abstract | Full Citation | Find Related Articles |
  |
